{
    "eid": "2-s2.0-85168331947",
    "title": "Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Rheumatology",
            "@code": "2745",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [],
    "authors": [
        "David R. Jayne",
        "J\u00fcrgen Steffgen",
        "Juanita Romero-Diaz",
        "Ingeborg Bajema",
        "Dimitrios T. Boumpas",
        "Kajohnsak Noppakun",
        "Hirofumi Amano",
        "Harold Michael Gomez",
        "Bancha Satirapoj",
        "Yingyos Avihingsanon",
        "Ratana Chawanasuntorapoj",
        "Magdalena Madero",
        "Beata Naumnik",
        "Rhona Recto",
        "Nora Fagan",
        "Ivette Revollo",
        "Jing Wu",
        "Sudha Visvanathan",
        "Richard Furie"
    ],
    "citedby-count": 0,
    "ref-count": 29,
    "ref-list": [
        "American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis",
        "Phoenix from the flames: rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis [review]",
        "2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis",
        "Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis",
        "Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study",
        "Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial",
        "Two-year, randomized, controlled trial of belimumab in lupus nephritis",
        "Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial",
        "Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation",
        "Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50",
        "B cells from African American lupus patients exhibit an activated phenotype",
        "Treatment with a CD40 antagonist antibody reverses severe proteinuria and loss of saliva production and restores glomerular morphology in murine systemic lupus erythematosus",
        "A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis",
        "An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases",
        "Safety, pharmacokinetics, and pharmacodynamics of multiple rising doses of BI 655064, an antagonistic anti-CD40 antibody, in healthy subjects: a potential novel treatment for autoimmune diseases",
        "Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study",
        "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus",
        "The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years",
        "The classification of glomerulonephritis in systemic lupus erythematosus revisited",
        "The classification of glomerulonephritis in systemic lupus erythematosus revisited",
        "Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0",
        "Design and analysis of dose-finding studies combining multiple comparisons and modeling procedures",
        "Qualification opinion of MCP-Mod as an efficient statistical methodology for model-based design and analysis of Phase II dose finding studies under model uncertainty",
        "A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis",
        "Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis",
        "Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis",
        "Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN): results from a large, nationwide, multicentric cohort",
        "CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study",
        "Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles"
    ],
    "affiliation": [
        {
            "affiliation-city": "Ingelheim am Rhein",
            "@id": "60011807",
            "affilname": "Boehringer Ingelheim Pharma GmbH &amp; Co. KG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011807",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "60120017",
            "affilname": "Department of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120017",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Angeles City",
            "@id": "60108103",
            "affilname": "Angeles University Foundation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108103",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Hempstead",
            "@id": "60107658",
            "affilname": "Donald and Barbara Zucker School of Medicine at Hofstra/Northwell",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60107658",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Ridgefield",
            "@id": "60105084",
            "affilname": "Boehringer Ingelheim Pharmaceuticals, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105084",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bialystok",
            "@id": "60026724",
            "affilname": "Uniwersytet Medyczny w Bialymstoku",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026724",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Athens",
            "@id": "60015528",
            "affilname": "Attikon University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015528",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Tlalpan",
            "@id": "60010748",
            "affilname": "Instituto Nacional de Cardiologia Ignacio Chavez",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010748",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60009740",
            "affilname": "Juntendo University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009740",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Tlalpan",
            "@id": "60009149",
            "affilname": "Instituto Nacional de la Nutrici\u00f3n Salvador Zubiran",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009149",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Groningen",
            "@id": "60006027",
            "affilname": "Universitair Medisch Centrum Groningen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006027",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lipa City",
            "@id": "126681739",
            "affilname": "Mary Mediatrix Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126681739",
            "affiliation-country": "Philippines"
        }
    ],
    "funding": [
        "Boehringer Ingelheim",
        "NIHR Cambridge Biomedical Research Centre"
    ]
}